Late gastrointestinal and urogenital side-effects after radiotherapy - Incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer

Radiotherapy and Oncology

Volumn 104, Issue 1, 2012, Pages 114-118

  Schmid, Maximilian P ^a   Pötter, Richard ^a   Bombosch, Valentin ^a   Sljivic, Samir ^a   Kirisits, Christian ^a   Dörr, Wolfgang ^a,b   Goldner, Gregor ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Dose escalation; Late side effects; Prostate cancer; Radiotherapy; Reporting

Indexed keywords

CANCER RADIOTHERAPY; DEFECATION URGENCY; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FECES INCONTINENCE; GASTROINTESTINAL SYMPTOM; HEMATURIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM DISEASE; RECTUM HEMORRHAGE; REVIEW; URINARY URGENCY; URINE INCONTINENCE; UROGENITAL TRACT DISEASE;

EID: 84863191363     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.05.007     Document Type: Article

References (36)

1. G. Goldner, S. Sljivic, and R. Oismüller Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat and treatment techniques based on data from 2007 Strahlenther Onkol 187 2011 279 283
2. S.T.H. Peeters, W.D. Heemsbergen, and P.C.M. Koper Dose-response in radiotherapy for localized prostate cancer: results of the dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 2006 1990 1996 (Pubitemid 46622106)
3. A. Al-Mamgani, W.D. Heemsbergen, P.C. Levendag, and J.V. Lebesque Subgroup analysis of patients with localized prostate cancer treated within the Dutch-randomized dose escalation trial Radiother Oncol 96 2010 13 18
4. G. Goldner, V. Bombosch, and H. Geinitz Moderate risk adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy Strahlenther Onkol 185 2009 94 100
5. G. Goldner, J. Dimopoulos, C. Kirisits, and R. Pötter Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: Single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy Strahlenther Onkol 185 2009 438 445
6. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129 (Pubitemid 351296130)
7. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74 (Pubitemid 350251041)
8. D.P. Dearnaley, E. Hall, and D. Lawrence Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects Br J Can 92 2005 488 498 (Pubitemid 40395529)
9. A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
10. Y. Maeda, M. Hoyer, L. Lundby, and C. Norton Faecal incontinence following radiotherapy for prostate cancer: a systematic review Radiother Oncol 98 2011 145 153
11. J. Noldus, U. Michl, M. Graefen, A. Haese, P. Hammerer, and H. Huland Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy Eur Urol 42 2002 118 124
12. W.J. Catalona, G.F. Carvalhal, D.E. Mager, and D.S. Smith Potency, continence and complication rates in 1870 consecutive radical retropubic prostatectomies J Urol 162 1999 433 438 (Pubitemid 29434355)
13. D. Christie, J. Denham, and A. Steigler Delayed rectal and rinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation Radiother Oncol 77 2005 117 125 (Pubitemid 41682375)
14. P.C. O'Brien, C.S. Hamilton, J.W. Denham, R. Gourlay, and C.I. Franklin Spontaneous improvement in late rectal mucosal changes following radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 58 2004 75 80 (Pubitemid 38010339)
15. G. Goldner, R. Pötter, A. Kranz, A. Bluhm, and W. Dörr Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy Strahlenther Onkol 187 2011 202 205
16. G.M. Duchesne, S.G. Williams, R. Das, and K.H. Tai Patterns of toxicity following high-dose rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results Radiother Oncol 84 2007 128 134 (Pubitemid 47284528)
17. C. Haie-Meder, A. Kramar, and P. Lambin Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma Int J Radiat Oncol Biol Phys 29 1994 953 960 (Pubitemid 24278960)
18. N. Gerstner, S. Wachter, D. Dorner, G. Goldner, A. Colotto, and R. Pötter Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma Strahlenther Onkol 175 1999 232 238 (Pubitemid 29237112)
19. R.J. Smeenk, B.S. The, E.B. Butler, E.N. van Lin, and J.H. Kaanders Is there a role for endorectal balloons in prostate radiotherapy? A systematic review Radiother Oncol 95 2010 277 282
20. ICRU. Report 62: prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda: International Commission on Radiation Units and Measurements; 1999.
21. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
22. A. Trotti, T.F. Pajak, and C.K. Gwede TAME: development of a new method for summarising adverse events of cancer treatment by the radiation therapy oncology group Lancet Oncol 8 2007 613 624 (Pubitemid 46995620)
23. S.L. Gulliford, M. Partridge, M.R. Sydes, J. Andreyev, and D.P. Dearnaley A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicities Radiother Oncol 94 2010 241 247
24. S.M. Bentzen, and A. Trotti Evaluation of early and late toxicities in chemoradiation trials J Clin Oncol 25 2007 4096 4103 (Pubitemid 47492954)
25. J.S.Y. Wu, P.M.A. Brasher, and A. El-Gayed Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: Outcomes of 55Gy in 16 fractions at 3.4 Gy per fraction Radiother Oncol 103 2012 210 216
26. P.J. Eifel, C. Levenback, T. Wharton, and M.J. Oswald Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix Int J Rad Oncol Biol Phys 32 1995 1289 1300
27. A. Capp, M. Inostroza-Ponta, and D. Bill Is there more than one proctitis syndrome? A revisitation using data from TROG 96.01 trial Radiother Oncol 90 2009 400 407
28. S. Marzi, G. Iaccarino, and K. Pasciuti Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity modulated radiotherapy Int J Rad Oncol Biol Phys 73 2009 1252 1259
29. M. Stock, W. Dörr, and C. Stromberger Investigations on parotid gland recovery after IMRT in head and neck tumor patients Strahlenther Onkol 186 2010 665 671
30. S. Delanian, C. Chantel, R. Procher, J. Depondt, and J.L. Lefaix Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clondronate combination (PENTOCLO): a phase II trial Int J Radiat Oncol Biol Phys 80 2011 832 839
31. S. Delanian, R. Procher, S. Balla-Mekias, and J.L. Lefaix Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis J Clin Oncol 21 2003 2545 2550 (Pubitemid 46606336)
32. F. Sieber, S.A. Muir, and E.P. Cohen High-dose selenium for the mitigation of radiation injury; a pilot study in a rat model Radiat Res 171 2009 368 373
33. P.J. Hoskin, A.M. Rojas, P.J. Bownes, G.J. Lowe, P.J. Ostler, and L. Bryant Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer Radiother Oncol 103 2012 217 222
34. S.L. Gulliford, M. Partridge, and M.R. Sydes Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise Radiother Oncol 102 2012 347 351
35. T. Rancati, C. Fiorino, and G. Fellin Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer Radiother Oncol 100 2011 124 130
36. G. Goldner, R. Pötter, and J.J. Battermann Comparison between external beam radiotherapy (70Gy/74Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients Radiother Oncol 103 2012 223 227